Possible mechanisms of the protective effect of ginsenoside Rg1 on apoptosis in substantia nigra neurons

Yaoxue Xuebao

Volumn 37, Issue 4, 2002, Pages 249-252

  Chen, Ying ^a   Chen, Xiao Chun ^a  

^a BEIJING HOSPITAL   (China)

Author keywords

Apoptosis; Caspase 3; Ginsenoside Rg1; Nitric oxide synthase; Substantia nigra neuron

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; CASP3 PROTEIN, MOUSE; CASPASE; CASPASE 3; GINSENOSIDE; GINSENOSIDE RG 1; NEURONAL NITRIC OXIDE SYNTHASE; NEUROPROTECTIVE AGENT; NITRIC OXIDE SYNTHASE; NOS1 PROTEIN, MOUSE;

ANIMAL; APOPTOSIS; ARTICLE; C57BL MOUSE; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; MALE; METABOLISM; MOUSE; NERVE CELL; PARKINSON DISEASE; PATHOLOGY; RANDOMIZATION; SUBSTANTIA NIGRA;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ANIMALS; APOPTOSIS; CASPASE 3; CASPASES; GINSENOSIDES; MALE; MICE; MICE, INBRED C57BL; NEURONS; NEUROPROTECTIVE AGENTS; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE I; PARKINSON DISEASE, SECONDARY; RANDOM ALLOCATION; SUBSTANTIA NIGRA;

EID: 0042884138     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Zhang JT. Retrospect and prospect of Ginseng research [J]. Acta Pharm Sin, 1995, 30(5):321-325.
2. Li JQ, Zhang XG, Zhang JT. Study on the anti-apoptotic mechanism of ginsenoside Rg1 in cultured cortical neurons [J]. Acta Pharm Sin, 1997, 32(6):406-410.
3. Chen XC, Zhu YG, Wang XZ, et al. Possible mechanism of the protective effects of ginsenoside Rg1 on apoptosis in PC12 cells [J]. Acta Pharm Sin, 2001, 36(6):411 -414.
4. Mochizuki H, Mori H, Mizuno Y. Apoptosis in neurodegenerative disorders [J]. J Neural Transm, 1997, 50 (Suppl):125-140.
5. Chen SD, Xu DL, Yu HZ, et al. Study on 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydro-pyridine-induced Parkinson's disease animal model [J]. Chin Med J, 1990, 70(5):252-254.
6. Costantini LC, Vozza BM, Snyder-keller AM. Enhanced efficacy of nigral-striatal cotransplants in bilaterally dopamine-depleted rats: an anatomical and behavioral analysis [J]. Exp Neurol, 1994, 127(2):219-231.
7. Tatton NA, Kish SJ. In situ detection of apoptotic nuclei in the substantia nigra compacta of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice using terminal deoxynucleotidyl transferase labelling and acridine orange staining [J]. Neuroscience, 1997, 77(4):1037-1048.
8. Hartmann A, Hunot S, Michel PP. Caspase-3: A vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease [J]. Proc Natl Acad Sci USA, 2000, 97(6):2875-2880.
9. Andrew PJ, Mayer B. Enzymatic function of nitric oxide synthases [J]. Cardiovasc Res, 1999, 43(3):521-531.
10. Heneka MT, Feinstein DL, Galea E, et al. Peroxisome proliferator-activated receptor gamma agonists protect cerebellar granule cells from cytokine-induced apoptotic cell death by inhibition of inducible nitric oxide synthase [J]. J Neuroimmunol, 1999, 100(1-2):156-168.
11. Tamatani M, Ogawa S, Nitsu Y, et al. Involvement of Bcl-2 family and caspase-3-like protease in NO-mediated neuronal apoptosis [J]. J Neurochem, 1998, 71(4):1588-1596.